Inventor
Frederick J. Cassels
Inventor
Ellicott City, MD, US
Overview
Patents· 16 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
C07KPeptides19%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations12%
C12NMicroorganisms or enzymes10%
Y02ATechnologies for adaptation to climate change10%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture8%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests6%
A61QSpecific use of cosmetics or similar toiletry preparations4%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
PatentTitleYear
7,625,571'Transformed bacteria producing CS6 antigens as vaccines'20097,604,811'Oral-intestinal vaccines against diseases caused by enteropathic organisms using antigens encapsulated within biodegradable-biocompatible microspheres'20097,566,540'Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein'20097,527,802'Vaccine for transcutaneous immunization'20097,404,961'Peptides responsive to antibodies against consensus peptide of the CS4-CFA/I family proteins'20087,332,172'Transformed bacteria producing CS6 antigens as vaccines'20087,217,541'Method of making CS6 antigen vaccine for treating, preventing, or inhibiting enterotoxigenic Escherichia coli infections'20077,094,883'Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein'20066,869,602'Method for treating, preventing, or inhibiting enterotoxigenic Escherichia coli infections with bovine red blood cells'20056,844,010'Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix'20056,797,485'Mass spectrometry of colonization factors'20046,309,669'Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix'20015,914,114'Method of raising antibodies against E. coli of the family CS4-CFA/I'19995,698,416'Methods for production of antigens under control of temperature-regulated promotors in enteric bacteria'19975,190,746'Plaque inhibiting oligosaccharide'19935,071,977'Plaque inhibiting oligosaccharide'1991Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1991–1993Patents assigned to US HEALTH (2)· patent assignee history
1991–2009Based in Gaithersburg, MD, US· patent location history
1997–2009Patents assigned to US ARMY (14)· patent assignee history
1997–2007Based in Ellicott City, MD, US· patent location history
2008–2009Based in Laurel, MD, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| US ARMY | 14 | 1997–2009 |
| US HEALTH | 2 | 1991–1993 |
Locations
| Location | Patents | Span |
|---|---|---|
| Ellicott City, Maryland, US | 8 | 1997–2007 |
| Laurel, Maryland, US | 5 | 2008–2009 |
| Gaithersburg, Maryland, US | 3 | 1991–2009 |